Cryo-Cell International Inc. (CCEL) Stock Price

CCELStock

$4.42−2.86%52W

Market Cap$35.64M

P/E69.51x

PEG Ratio1.34

Div yield11.76%

Beta0.60

CCEL Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)12.87%

Price vs S&P 500 (4W)26.54%

PEG Ratio1.34

VGM Score43.14

P/E Ratio (Annual)69.51x

Indicated Dividend Yield (Annual)11.76%

P/CF (Annual)6.50x

Book Value / Share (Quarterly)$0.52

P/TBV (Annual)40.23x

Revenue Growth (3Y)1.33%

Cash Flow / Share (Quarterly)$0.58

Payout Ratio (TTM)1102.49%

Price vs S&P 500 (YTD)16.77%

Gross Margin (TTM)78.54%

Net Profit Margin (TTM)-6.25%

EPS (TTM)$-0.24

10-Day Avg Trading Volume0.02M

EPS Excl Extra (TTM)$-0.24

Revenue Growth (5Y)0.27%

EPS (Annual)$-0.30

Dividend / Share (Annual)$0.40

ROI (Annual)34.26%

Gross Margin (Annual)76.63%

Net Profit Margin (5Y Avg)-4.09%

Cash / Share (Quarterly)$0.52

Revenue Growth QoQ (YoY)-0.02%

EPS Growth (5Y)-29.04%

P/E Normalized (Annual)69.51x

ROA (Last FY)-3.94%

Revenue Growth TTM (YoY)-1.96%

EBITD / Share (TTM)$0.11

ROE (5Y Avg)48.39%

Operating Margin (TTM)0.61%

Cash Flow / Share (Annual)$0.65

P/B Ratio8.09x

P/B Ratio (Quarterly)10.59x

Net Income / Employee (Annual)$-33,700

EV / Revenue (TTM)1.36x

Net Interest Coverage (TTM)0.19x

ROA (TTM)-3.17%

EPS Growth QoQ (YoY)69.72%

EV / EBITDA (TTM)45.85x

EPS Incl Extra (Annual)$-0.30

Current Ratio (Annual)0.59x

Quick Ratio (Quarterly)0.79x

3-Month Avg Trading Volume0.02M

52-Week Price Return-2.86%

EV / Free Cash Flow (Annual)8.09x

Revenue / Employee (TTM)$432,300

Tangible BV / Share (Quarterly)$0.34

P/S Ratio (Annual)1.13x

Asset Turnover (Annual)0.51x

52-Week High$4.90

Operating Margin (5Y Avg)0.07%

EPS Excl Extra (Annual)$-0.30

CapEx CAGR (5Y)18.18%

26-Week Price Return22.78%

Quick Ratio (Annual)0.54x

13-Week Price Return27.75%

Total Debt / Equity (Annual)0.45x

Current Ratio (Quarterly)0.86x

Enterprise Value$42.45M

Revenue / Share Growth (5Y)0.44%

Asset Turnover (TTM)0.51x

Revenue / Employee (Annual)$438,400

Inventory Turnover (Annual)13.83x

Pretax Margin (Annual)-7.40%

Cash / Share (Annual)$0.41

3-Month Return Std Dev90.89%

Gross Margin (5Y Avg)72.95%

Net Income / Employee (TTM)$-27,000

EBITDA CAGR (5Y)-28.83%

EBITDA Interim CAGR (5Y)4.97%

ROE (Last FY)49.79%

Net Interest Coverage (Annual)0.10x

EPS Basic Excl Extra (Annual)$-0.30

P/FCF (TTM)7.66x

Receivables Turnover (TTM)4.55x

EV / Free Cash Flow (TTM)9.13x

Total Debt / Equity (Quarterly)0.08x

EPS Incl Extra (TTM)$-0.24

Receivables Turnover (Annual)4.46x

ROI (TTM)28.47%

P/S Ratio (TTM)1.14x

Pretax Margin (5Y Avg)-4.26%

Revenue / Share (Annual)$3.91

Tangible BV / Share (Annual)$0.31

Forward P/E40.18x

Free OCF CAGR (5Y)-8.91%

Price vs S&P 500 (52W)-18.39%

Year-to-Date Return28.49%

5-Day Price Return-1.78%

EPS Normalized (Annual)$-0.30

ROA (5Y Avg)-2.23%

Net Profit Margin (Annual)-7.70%

Month-to-Date Return5.24%

Cash Flow / Share (TTM)$0.47

EBITD / Share (Annual)$0.15

EPS Growth (3Y)-41.85%

Operating Margin (Annual)1.53%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)7.24x

ROI (5Y Avg)45.26%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.24

P/TBV (Quarterly)16.12x

Payout Ratio (Annual)502.50%

P/B Ratio (Annual)25.24x

Dividend / Share (TTM)$0.00

Inventory Turnover (TTM)11.24x

Pretax Margin (TTM)-6.13%

Book Value / Share (Annual)$0.49

Price vs S&P 500 (13W)25.06%

Net Margin Growth (5Y)-29.43%

Dividend Yield (TTM)0.00%

Beta0.60x

P/FCF (Annual)6.79x

Revenue / Share (TTM)$3.86

ROE (TTM)38.23%

52-Week Low$2.72

vGradeC

gGradeD

mGradeB

vgmGradeC

CCEL Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q3 2026	Oct 9, 2026	$0.03	$0.17	+451.70%(+$0.14)
Q2 2026	Jul 15, 2026	$0.00	$0.07	+0.00%(+$0.07)
Q1 2026	Apr 14, 2026	-$0.02	$0.02	+195.00%(+$0.04)
Q4 2025	Feb 27, 2026	-$0.09	-$0.47	-417.33%(-$0.38)
Q3 2025	Oct 15, 2025	-$0.03	$0.10	+419.00%(+$0.13)

CCEL Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

2.17

Industry Peers — Health Services(17)

Symbol	Value Score	Growth Score	Momentum Score	P/E Ratio (Annual)	Revenue Growth TTM (YoY)	Operating Margin (TTM)	ROE (TTM)	Price
CCELCryo-Cell International Inc.	C	D	B	69.5x	-2.0%	0.6%	38.2%	$4.42
DVADaVita Inc.	B	C	B	16.0x	6.5%	15.1%	181.2%	$187.31
FMSFresenius Medical Care AG	A	D	C	10.7x	-0.5%	9.4%	7.2%	$22.17
SHCSotera Health Company Common Stock	D	B	C	65.5x	8.2%	32.6%	26.8%	$17.89
PGNYProgyny, Inc. Common Stock	C	B	C	35.2x	5.5%	8.6%	16.0%	$26.86
AGLagilon health, inc.	B	B	B	—	0.3%	-5.2%	-110.3%	$85.12
MCTACharming Medical Limited Class A Ordinary Shares	F	F	A	371.6x	—	15.4%	—	$29.36
VMDViemed Healthcare, Inc. Common Shares	B	C	C	24.2x	25.2%	7.5%	10.3%	$9.48
PARKPark Dental Partners, Inc. Common Stock	B	F	C	17.9x	—	-2.8%	-18.3%	$18.95
MGRXMangoceuticals, Inc. Common Stock	D	F	F	—	-38.9%	-4761.2%	-106.1%	$0.29
BRTXBioRestorative Therapies, Inc. Common Stock (NV)	—	D	F	—	-8.5%	-3975.0%	-423.8%	$1.54
NIVFNewGenIvf Group Limited Class A ordinary shares	A	C	F	0.3x	—	390.2%	45.4%	$0.28
NIVFWNewGenIvf Group Limited Warrants	—	—	D	—	—	—	—	$0.01
OAKUOak Woods Acquisition Corporation Class A Ordinary Shares	—	F	B	174.5x	—	—	-0.6%	$0.00
OAKUROak Woods Acquisition Corporation Right	—	F	B	174.5x	—	—	-0.6%	$0.00
OAKUUOak Woods Acquisition Corporation Unit	—	F	B	174.5x	—	—	-0.6%	$0.00
OAKUWOak Woods Acquisition Corporation Warrant	—	—	F	—	—	—	—	$0.00
QIPTQuipt Home Medical Corp. Ordinary Shares	B	B	B	—	9.5%	-1.2%	-10.5%	$0.00

About Cryo-Cell International Inc.

Cryo-Cell International Inc specializes in the collection, processing, and cryogenic storage of umbilical cord blood and tissue stem cells for both private family banking and public banking applications. The company operates through three segments: private cellular banking services, public cord blood banking, and its PrepaCyte CB processing technology platform. Revenue is generated from processing fees, testing services, and long-term cryogenic storage.